KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt RepaymentsR&D In ProcessShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Pfizer (PFE) Shares Outstanding (2016 - 2022)

Historic Shares Outstanding for Pfizer (PFE) over the last 13 years, with Q2 2022 value amounting to $9.5 billion.

  • Pfizer's Shares Outstanding rose 51.88% to $9.5 billion in Q2 2022 from the same period last year, while for Apr 2022 it was $9.5 billion, marking a year-over-year increase of 51.88%. This contributed to the annual value of $9.5 billion for FY2021, which is 68.03% up from last year.
  • Latest data reveals that Pfizer reported Shares Outstanding of $9.5 billion as of Q2 2022, which was up 51.88% from $9.5 billion recorded in Q4 2021.
  • Pfizer's Shares Outstanding's 5-year high stood at $9.5 billion during Q2 2022, with a 5-year trough of $9.3 billion in Q2 2018.
  • For the 5-year period, Pfizer's Shares Outstanding averaged around $9.4 billion, with its median value being $9.4 billion (2020).
  • Its Shares Outstanding has fluctuated over the past 5 years, first soared by 33.1% in 2020, then skyrocketed by 69.17% in 2021.
  • Pfizer's Shares Outstanding (Quarter) stood at $9.3 billion in 2018, then increased by 0.4% to $9.4 billion in 2019, then grew by 0.41% to $9.4 billion in 2020, then grew by 0.68% to $9.5 billion in 2021, then rose by 0.24% to $9.5 billion in 2022.
  • Its last three reported values are $9.5 billion in Q2 2022, $9.5 billion for Q4 2021, and $9.5 billion during Q4 2021.